sulfinpyrazone has been researched along with Death, Sudden in 37 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
Death, Sudden: The abrupt cessation of all vital bodily functions, manifested by the permanent loss of total cerebral, respiratory, and cardiovascular functions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The results of the Anturane Reinfarction Trial, a randomized, double-blind, multicenter clinical trial, represent the data on 1558 patients who received either sulfinpyrazone or placebo for an average of 16 months, starting 25 to 35 days after a documented myocardial infarction." | 9.05 | [Sulfinpyrazone in the prevention of sudden death after myocardial infarction (author's transl)]. ( Sherry, S, 1980) |
| "We report the results of a randomized double-blind, multicenter trial comparing sulfinpyrazone (200 mg four times a day) and a placebo in the prevention of cardiac mortality among 1558 patients followed for an average of 16 months, beginning 25 to 35 days after a documented myocardial infarction." | 9.05 | Sulfinpyrazone in the prevention of sudden death after myocardial infarction. ( , 1980) |
| "The Anturane Reinfarction Trial is a randomized, double-blind, multicenter clinical trial comparing sulfinpyrazone (200 mg four times a day) and placebo in the prevention of cardiac mortality among patients with a recent documented myocardial infarction." | 9.04 | Sulfinpyrazone in the prevention of cardiac death after myocardial infarction. The Anturane Reinfarction Trial. ( , 1978) |
| "The results of the Anturane Reinfarction Trial, a randomized, double-blind, multicenter clinical trial, represent the data on 1558 patients who received either sulfinpyrazone or placebo for an average of 16 months, starting 25 to 35 days after a documented myocardial infarction." | 5.05 | [Sulfinpyrazone in the prevention of sudden death after myocardial infarction (author's transl)]. ( Sherry, S, 1980) |
| "We report the results of a randomized double-blind, multicenter trial comparing sulfinpyrazone (200 mg four times a day) and a placebo in the prevention of cardiac mortality among 1558 patients followed for an average of 16 months, beginning 25 to 35 days after a documented myocardial infarction." | 5.05 | Sulfinpyrazone in the prevention of sudden death after myocardial infarction. ( , 1980) |
| "The Anturane Reinfarction Trial evaluated the effect of sulfinpyrazone (Anturane) (200 mg four times a day) vs placebo on cardiac mortality rates among patients recently recovered from an acute myocardial infarction." | 5.05 | The anturane reinfarction trial. ( Sherry, S, 1980) |
| "The Anturane Reinfarction Trial is a randomized, double-blind, multicenter clinical trial comparing sulfinpyrazone (200 mg four times a day) and placebo in the prevention of cardiac mortality among patients with a recent documented myocardial infarction." | 5.04 | Sulfinpyrazone in the prevention of cardiac death after myocardial infarction. The Anturane Reinfarction Trial. ( , 1978) |
| "In a sulfinpyrazone-treated group 3 out of 8, and in a metoprolol-treated group 2 out of 5 animals died." | 1.27 | Sudden death related to advanced coronary atherosclerosis in mini-pigs: influence of some drugs. ( Jacobsson, L; Lundholm, L; Wingren, G, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 37 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braunwald, E | 1 |
| Walter, E | 1 |
| Staiger, C | 1 |
| Rothlin, M | 1 |
| Boissel, JP | 1 |
| Leizorovicz, A | 1 |
| Faucomprez, C | 1 |
| Genton, E | 2 |
| Bender, F | 1 |
| Spann, JF | 1 |
| Chodorowski, Z | 1 |
| Smith, JW | 1 |
| Jacobsson, L | 1 |
| Lundholm, L | 1 |
| Wingren, G | 1 |
| Bolte, HD | 1 |
| Sherry, S | 3 |
| Schiff, AA | 1 |
| Shepard, DS | 1 |
| Zeckhauser, RJ | 1 |
| Kolata, GB | 1 |
| Gent, M | 1 |
| Barnett, HJ | 1 |
| Sackett, DL | 1 |
| Taylor, DW | 1 |
| Pentecost, BL | 1 |
| Prentice, CR | 1 |
| Hirsh, J | 1 |
| Cowan, JC | 1 |
| Williams, EM | 1 |
| Foz, M | 1 |
| Nestel, PJ | 1 |
| Relman, AS | 2 |
| Temple, R | 1 |
| Pledger, GW | 1 |
| Steele, P | 1 |
| Rainwater, J | 1 |
| Vogel, R | 1 |
| Mustard, JF | 1 |
| Packham, MA | 1 |
| Kinlough-Rathbone, RL | 1 |
| Gelman, JS | 1 |
| Mehta, J | 1 |
| Chamberlain, DA | 1 |
| Jouve, R | 1 |
| Larrue, J | 1 |
6 reviews available for sulfinpyrazone and Death, Sudden
| Article | Year |
|---|---|
Cardiac death prevention in post-myocardial infarction patients: a review.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Animals; Anti-Arrhythmia Agents; Anticoagu | 1980 |
Changing concepts of pathophysiology, prognosis, and therapy in acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aspirin; Coronary Disease; Coronary Vasospasm; Death, Sudden; Dipyridam | 1983 |
[Perspectives of the preventive treatment of patients after myocardial infarction].
Topics: Adrenergic beta-Antagonists; Aspirin; Coronary Disease; Death, Sudden; Exercise Therapy; Humans; Myo | 1984 |
Myocardial infarction.
Topics: Anticoagulants; Aspirin; Blood Platelets; Death, Sudden; Dipyridamole; Fibrinolytic Agents; Humans; | 1981 |
Antiplatelet agents: their role in the prevention of sudden death.
Topics: Animals; Aspirin; Blood Platelets; Cell Survival; Clinical Trials as Topic; Coronary Circulation; Co | 1982 |
Platelets and prostaglandins in sudden death: therapeutic implications.
Topics: Adrenergic beta-Antagonists; Animals; Arachidonic Acid; Arachidonic Acids; Arteriosclerosis; Aspirin | 1985 |
17 trials available for sulfinpyrazone and Death, Sudden
| Article | Year |
|---|---|
Sulphinpyrazone, aspirin, and uric acid.
Topics: Aspirin; Death, Sudden; Humans; Myocardial Infarction; Sulfinpyrazone; Uric Acid | 1980 |
The anturane reinfarction trial.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Death, Sudden; Humans; Myocardial Infarction; | 1980 |
Cardiac death prevention in post-myocardial infarction patients: a review.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Animals; Anti-Arrhythmia Agents; Anticoagu | 1980 |
A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease.
Topics: Adrenergic beta-Antagonists; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascula | 1980 |
[Sulfinpyrazone in the prevention of sudden death after myocardial infarction (author's transl)].
Topics: Adult; Aged; Death, Sudden; Female; Heart Arrest; Humans; Male; Middle Aged; Myocardial Infarction; | 1980 |
Sulfinpyrazone in the prevention of sudden death after myocardial infarction.
Topics: Aged; Clinical Trials as Topic; Death, Sudden; Double-Blind Method; Female; Follow-Up Studies; Human | 1980 |
Anturan: new use for an old drug.
Topics: Arrhythmias, Cardiac; Clinical Trials as Topic; Death, Sudden; Humans; Myocardial Infarction; Sulfin | 1980 |
The anturane reinfarction trial.
Topics: Clinical Trials as Topic; Death, Sudden; Humans; Myocardial Infarction; Sulfinpyrazone | 1980 |
The anturane reinfarction trial.
Topics: Clinical Trials as Topic; Death, Sudden; Humans; Myocardial Infarction; Sulfinpyrazone | 1980 |
FDA says no to anturane.
Topics: Anticoagulants; Clinical Trials as Topic; Death, Sudden; Humans; Legislation, Drug; Myocardial Infar | 1980 |
A randomized trial of aspirin and sulfinpyrazone in patients with threatened stroke. Results and methodologic issues.
Topics: Actuarial Analysis; Aspirin; Canada; Cerebrovascular Disorders; Clinical Trials as Topic; Death, Sud | 1980 |
Preventing the second infarct.
Topics: Adult; Animals; Clinical Trials as Topic; Death, Sudden; Dogs; Electrocardiography; Exercise Therapy | 1980 |
Antiplatelet agents: their role in the prevention of sudden death.
Topics: Animals; Aspirin; Blood Platelets; Cell Survival; Clinical Trials as Topic; Coronary Circulation; Co | 1982 |
The anturane reinfarction trial.
Topics: Aspirin; Blood Platelets; Death, Sudden; Female; Humans; Male; Myocardial Infarction; Placebos; Sulf | 1980 |
Sulfinpyrazone in the prevention of cardiac death after myocardial infarction. The Anturane Reinfarction Trial.
Topics: Aged; Blood Platelets; Clinical Trials as Topic; Death, Sudden; Depression, Chemical; Double-Blind M | 1978 |
Overview of completed sudden death trials: European experience.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Aspirin; Calcium Channel Blockers; Clinical Tri | 1987 |
[Eicosanoids, myocardial ischemia and sudden death].
Topics: Animals; Arrhythmias, Cardiac; Aspirin; Clinical Trials as Topic; Coronary Disease; Cyclooxygenase I | 1985 |
16 other studies available for sulfinpyrazone and Death, Sudden
| Article | Year |
|---|---|
Treatment of the patient after myocardial infarction. The last decade and the next.
Topics: Adrenergic beta-Antagonists; Aspirin; Death, Sudden; Exercise Therapy; Humans; Myocardial Infarction | 1980 |
[Prevention of sudden cardiac death].
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Death, Sudden; Heart Arrest; Humans; Sulfinpyra | 1980 |
Mortality after recovery from myocardial infarction.
Topics: Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Death, Sudden; Heart Failure; Humans; Myocardi | 1980 |
Sudden death related to advanced coronary atherosclerosis in mini-pigs: influence of some drugs.
Topics: Animals; Cholesterol; Coronary Circulation; Coronary Disease; Coronary Vessels; Creatine Kinase; Dea | 1984 |
[Sulfinpyrazone (Anturane)--new indication: myocardial infarct?].
Topics: Arrhythmias, Cardiac; Aspirin; Death, Sudden; Humans; Myocardial Infarction; Platelet Aggregation; S | 1980 |
[The Anturan reinfarct study].
Topics: Aged; Coronary Disease; Death, Sudden; Female; Humans; Male; Middle Aged; Myocardial Infarction; Pla | 1980 |
The anturane reinfarction trial.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Death, Sudden; Guinea Pigs; In Vitro Techniques; | 1980 |
Drug reduces incidence of sudden cardiac death.
Topics: Aged; Death, Sudden; Double-Blind Method; Drug Evaluation; Humans; Middle Aged; Myocardial Infarctio | 1980 |
[Sulfinpyrazone in the prevention of sudden cardiac death after myocardial infarct].
Topics: Anti-Arrhythmia Agents; Death, Sudden; Humans; Myocardial Infarction; Sulfinpyrazone | 1980 |
Post-infarct sudden deaths curbed by sulfinpyrazone.
Topics: Canada; Death, Sudden; Double-Blind Method; Humans; Myocardial Infarction; Random Allocation; Sulfin | 1980 |
Sulfinpyrazone after myocardial infarction.
Topics: Australia; Death, Sudden; Humans; Myocardial Infarction; Recurrence; Risk; Sulfinpyrazone | 1980 |
Sulfinpyrazone after myocardial infarction: no decision yet.
Topics: Clinical Trials as Topic; Death, Sudden; Humans; Myocardial Infarction; Research Design; Sulfinpyraz | 1980 |
The FDA's critique of the anturane reinfarction trial.
Topics: Clinical Trials as Topic; Death, Sudden; Double-Blind Method; Humans; Myocardial Infarction; Placebo | 1980 |
Platelet-suppressant therapy in patients with coronary artery disease.
Topics: Adult; Blood Platelets; Cell Survival; Clofibrate; Coronary Artery Bypass; Coronary Disease; Death, | 1978 |
New job for an old drug?
Topics: Blood Platelets; Death, Sudden; Humans; Myocardial Infarction; Recurrence; Sulfinpyrazone; Time Fact | 1978 |
Effect of drugs of platelets and complications of vascular disease.
Topics: Animals; Anticoagulants; Aspirin; Blood Coagulation; Blood Platelets; Clofibrate; Coronary Disease; | 1977 |